Morinobu S, et al. Prevalence of disease-specific antinuclear an- tibodies in general population: estimates from annual physical examinations of residents of a small town over a 5-year period. Mod Rheumatol 2008;18:153-60. [CrossRef]
Kumar Y, Bhatia A, Minz RW. Antinuclear antibodies and their detection methods in diagnosis of connective tissue diseases: a journey revisited. Diagn Pathol 2009;4:1. [CrossRef]
Pisetsky DS. Antinuclear antibodies in healthy people: the tip of autoimmunity’s iceberg? Arthritis Res Ther 2011;13:109-10. [CrossRef]
Marin GG, Cardiel MH, Cornejo H, Viveros ME. Prevalence of antinuclear antibodies in 3 groups of healthy individuals: blood donors, hospital personnel, and relatives of patients with autoim- mune diseases. J Clin Rheumatol 2009;15:325-9. [CrossRef]
de Vlam K, De Keyser F, Verbruggen G, Vandenbossche M, Van- neuville B, D’Haese D, et al. Detection and identification of anti- nuclear autoantibodies in the serum of normal blood donors. Clin Exp Rheumatol 1993;11:393-7.
Vazquez-Del Mercado M, Gonzalez-Bernaldez M, Garcia-De La Torre I. Prevalence of antinuclear antibodies in a Huichol popula- tion of Mexico. Lupus 1995;4:164-5. [CrossRef]
Fernandez SA, Lobo AZ, Oliveira ZN, Fukumori LM, P rigo AM, Rivitti EA. Prevalence of antinuclear autoantibodies in the se- rum of normal blood donors. Rev Hosp Clín Fac Med S Paulo 2003;58:315-9. [CrossRef]
Al Jabri AA, Al Belushi MS, Nsanze H. Frequency and levels of otoantibodies in healthy adult Omanis. Ann Saudi Med 2003;23:372-5.
Satoh M, Chan EK, Ho LA, Rose KM, Parks CG, Cohn RD, et al. Prevalence and sociodemographic correlates of antinuclear an- tibodies in the United States. Arthritis Rheum 2012;64:2319-27. [CrossRef]
Hayashi N, Koshiba M, Nishimura K, Sugiyama D, Nakamura T, Morinobu S, et al. Prevalence of disease-specific antinuclear an- tibodies in general population: estimates from annual physical examinations of residents of a small town over a 5-year period. Mod Rheumatol 2008;18:153-60. [CrossRef]
Topbas M, Can E, Kaklikkaya N, et al. Herpes Simplex-2 serop- revalence among adults aged 20-49 in Trabzon. Nobel Med 2012;8:85-90.
Determination of Anti-Nuclear Antibody Seroprevalence in Adult Age Groups in Trabzon Province
Kumar Y, Bhatia A, Minz RW. Antinuclear antibodies and their detection methods in diagnosis of connective tissue diseases: a journey revisited. Diagn Pathol 2009;4:1. [CrossRef]
Pisetsky DS. Antinuclear antibodies in healthy people: the tip of autoimmunity’s iceberg? Arthritis Res Ther 2011;13:109-10. [CrossRef]
Marin GG, Cardiel MH, Cornejo H, Viveros ME. Prevalence of antinuclear antibodies in 3 groups of healthy individuals: blood donors, hospital personnel, and relatives of patients with autoim- mune diseases. J Clin Rheumatol 2009;15:325-9. [CrossRef]
de Vlam K, De Keyser F, Verbruggen G, Vandenbossche M, Van- neuville B, D’Haese D, et al. Detection and identification of anti- nuclear autoantibodies in the serum of normal blood donors. Clin Exp Rheumatol 1993;11:393-7.
Vazquez-Del Mercado M, Gonzalez-Bernaldez M, Garcia-De La Torre I. Prevalence of antinuclear antibodies in a Huichol popula- tion of Mexico. Lupus 1995;4:164-5. [CrossRef]
Fernandez SA, Lobo AZ, Oliveira ZN, Fukumori LM, P rigo AM, Rivitti EA. Prevalence of antinuclear autoantibodies in the se- rum of normal blood donors. Rev Hosp Clín Fac Med S Paulo 2003;58:315-9. [CrossRef]
Al Jabri AA, Al Belushi MS, Nsanze H. Frequency and levels of otoantibodies in healthy adult Omanis. Ann Saudi Med 2003;23:372-5.
Satoh M, Chan EK, Ho LA, Rose KM, Parks CG, Cohn RD, et al. Prevalence and sociodemographic correlates of antinuclear an- tibodies in the United States. Arthritis Rheum 2012;64:2319-27. [CrossRef]
Hayashi N, Koshiba M, Nishimura K, Sugiyama D, Nakamura T, Morinobu S, et al. Prevalence of disease-specific antinuclear an- tibodies in general population: estimates from annual physical examinations of residents of a small town over a 5-year period. Mod Rheumatol 2008;18:153-60. [CrossRef]
Topbas M, Can E, Kaklikkaya N, et al. Herpes Simplex-2 serop- revalence among adults aged 20-49 in Trabzon. Nobel Med 2012;8:85-90.
Kaklıkkaya, N., Akıneden, A., Topbaş, M., Aydın, F. (2013). Determination of Anti-Nuclear Antibody Seroprevalence in Adult Age Groups in Trabzon Province. Balkan Medical Journal, 2013(3).
AMA
Kaklıkkaya N, Akıneden A, Topbaş M, Aydın F. Determination of Anti-Nuclear Antibody Seroprevalence in Adult Age Groups in Trabzon Province. Balkan Medical Journal. Mart 2013;2013(3).
Chicago
Kaklıkkaya, Neşe, Altan Akıneden, Murat Topbaş, ve Faruk Aydın. “Determination of Anti-Nuclear Antibody Seroprevalence in Adult Age Groups in Trabzon Province”. Balkan Medical Journal 2013, sy. 3 (Mart 2013).
EndNote
Kaklıkkaya N, Akıneden A, Topbaş M, Aydın F (01 Mart 2013) Determination of Anti-Nuclear Antibody Seroprevalence in Adult Age Groups in Trabzon Province. Balkan Medical Journal 2013 3
IEEE
N. Kaklıkkaya, A. Akıneden, M. Topbaş, ve F. Aydın, “Determination of Anti-Nuclear Antibody Seroprevalence in Adult Age Groups in Trabzon Province”, Balkan Medical Journal, c. 2013, sy. 3, 2013.
ISNAD
Kaklıkkaya, Neşe vd. “Determination of Anti-Nuclear Antibody Seroprevalence in Adult Age Groups in Trabzon Province”. Balkan Medical Journal 2013/3 (Mart 2013).
JAMA
Kaklıkkaya N, Akıneden A, Topbaş M, Aydın F. Determination of Anti-Nuclear Antibody Seroprevalence in Adult Age Groups in Trabzon Province. Balkan Medical Journal. 2013;2013.
MLA
Kaklıkkaya, Neşe vd. “Determination of Anti-Nuclear Antibody Seroprevalence in Adult Age Groups in Trabzon Province”. Balkan Medical Journal, c. 2013, sy. 3, 2013.
Vancouver
Kaklıkkaya N, Akıneden A, Topbaş M, Aydın F. Determination of Anti-Nuclear Antibody Seroprevalence in Adult Age Groups in Trabzon Province. Balkan Medical Journal. 2013;2013(3).